Zobrazeno 1 - 10
of 18
pro vyhledávání: '"B. Grønvold"'
Autor:
M. Remberger, B. Grønvold, M. Ali, J. Mattsson, T. Egeland, K. U. Lundin, A. Myhre, I. Abrahamsen, D. Heldal, I. Dybedal, G. E. Tjønnfjord, T. Gedde-Dahl, Y. Fløisand
Publikováno v:
Clinical Hematology International, Vol 2, Iss 2 (2020)
The effect of CD34+ cell dose in allogeneic hematopoietic stem cell transplantation (HSCT) on overall survival (OS) and incidence of acute and chronic graft-versus-host disease (GvHD) has not been established and few studies have been performed. Our
Externí odkaz:
https://doaj.org/article/dcd573a286f44e1c836d2da62f9daeef
Autor:
B. Grønvold, Maryan Ali, Yngvar Fløisand, Ingerid Weum Abrahamsen, Jonas Mattsson, Ingunn Dybedal, Anders Eivind Myhre, Katrin U. Lundin, M. Remberger, Geir E. Tjønnfjord, Thore Egeland, T. Gedde-Dahl, D. Heldal
Publikováno v:
Bone Marrow Transplantation. 55:1658-1661
Publikováno v:
Journal of the Belgian Society of Radiology, Vol 95, Iss 5, Pp 302-305 (2012)
A variant vascular anatomy was detected during regular analysis of multidetector computed tomography angio - graphy of the abdomen in a 70 year-old female patient, referred to the department of surgery for laparoscopic right colectomy for colon cance
Externí odkaz:
https://doaj.org/article/d6719a82116249ccb449968e93eb13ee
Autor:
Anders Eivind Myhre, B. Grønvold, M. Remberger, Geir E. Tjønnfjord, T. Gedde-Dahl, Yngvar Fløisand, Ingerid Weum Abrahamsen, M.M. Ali
Publikováno v:
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
Anti-thymocyte globulin (ATG) is commonly used to prevent graft-versus-host disease (GvHD) after allogeneic hematopoietic stem cell transplantation (allo-HSCT). To evaluate the impact of ATG as part of the GvHD prophylaxis in our institution, we repo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b6205904ac775831f222e7a91124b40
http://hdl.handle.net/10852/93182
http://hdl.handle.net/10852/93182
Autor:
Nadia Mensali, Jonas Mattsson, Else Marit Inderberg, Tobias Gedde-Dahl, Ingerid Weum Abrahamsen, B. Grønvold
Publikováno v:
Case Reports in Immunology, Vol 2020 (2020)
Case Reports in Immunology
Case Reports in Immunology
Epstein–Barr virus- (EBV-) induced posttransplantation lymphoproliferative disease (PTLD) is a life-threatening complication following allogeneic stem cell transplantation. The main risk factor is anti-thymocyte globulin (ATG). Patients who fail fi
Autor:
M, Remberger, B, Grønvold, M, Ali, J, Mattsson, T, Egeland, K U, Lundin, A, Myhre, I, Abrahamsen, D, Heldal, I, Dybedal, G E, Tjønnfjord, T, Gedde-Dahl, Y, Fløisand
Publikováno v:
Clinical Hematology International
The effect of CD34+ cell dose in allogeneic hematopoietic stem cell transplantation (HSCT) on overall survival (OS) and incidence of acute and chronic graft-versus-host disease (GvHD) has not been established and few studies have been performed. Our
Autor:
B, Grønvold, M M, Ali, M, Remberger, J, Mattsson, T, Egeland, K U, Lundin, A E, Myhre, I W, Abrahamsen, D, Heldal, I, Dybedal, G E, Tjønnfjord, Y, Fløisand, T, Gedde-Dahl
Publikováno v:
Bone marrow transplantation. 55(8)
Autor:
Maryan Ali, Mats Remberger, Yngvar Fløisand, B. Grønvold, Tobias Gedde-Dahl, Ingerid Weum Abrahamsen, Geir E. Tjønnfjord, Anders Eivind Myhre, Katrin U. Lundin, Jonas Mattsson
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:S282
Background The age of patients admitted to HSCT is increasing. The median age of adult patients is close to 60 years at many centers. With a sibling donor this means that in most cases an older donor will be used. There are reports that donor age is
Autor:
Jonas Mattsson, Maryan Ali, Mats Remberger, B. Grønvold, Katrin U. Lundin, Ingunn Dybedal, Yngvar Fløisand, Anders Eivind Myhre, Geir E. Tjønnfjord, Tobias Gedde-Dahl, Ingerid Weum Abrahamsen
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:S279
Background The outcome of allogeneic hematopoietic stem cell transplantation (HSCT) is influenced by many factors (underlying disease, HLA-matching, patient and donor age, CMV serostatus, co-morbidities, conditioning regimen, GVHD prophylaxis and gra
Autor:
D. Heldal, T. Gedde-Dahl, I. Abrahamsen, M.M. Ali, M. Remberger, Katrin U. Lundin, J. Mattsson, B. Grønvold, Geir E. Tjønnfjord, Yngvar Fløisand, A. Myhre, Thore Egeland, I. Dybedal
Publikováno v:
Biology of Blood and Marrow Transplantation. 25:S298
High-resolution matching of donor-recipient HLA improves outcome in allogeneic stem cell transplants. Matching for HLA-A, -B, -C, –DRB1 and –DQ is mandatory in our transplant centre, to identify 10/10 or 9/10 matched unrelated donors. High resolu